{"id":"https://openalex.org/W7136186404","doi":"https://doi.org/10.6084/m9.figshare.4459904","title":"Additional file 5: Figure S3. of The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831","display_name":"Additional file 5: Figure S3. of The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W7136186404","doi":"https://doi.org/10.6084/m9.figshare.4459904"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.4459904","doi":"https://doi.org/10.6084/m9.figshare.4459904","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.4459904","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.4459904","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065306642","display_name":"Edith A. Perez","orcid":"https://orcid.org/0000-0002-5037-6677","observed_orcids":["https://orcid.org/0000-0002-5037-6677","https://orcid.org/0000-0001-7009-7467"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Perez, Edith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078606543","display_name":"Frederick L. Baehner","orcid":"https://orcid.org/0000-0001-6883-1212","observed_orcids":["https://orcid.org/0000-0001-6883-1212"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Baehner, Frederick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112832128","display_name":"Steven M. Butler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Butler, Steven","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159981714","display_name":"E. Thompson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thompson, E.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090009905","display_name":"Amylou Constance Dueck","orcid":"https://orcid.org/0000-0002-9912-1085","observed_orcids":["https://orcid.org/0000-0002-9912-1085"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dueck, Amylou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046532984","display_name":"Farid Jamshidian","orcid":"https://orcid.org/0009-0004-6181-9877","observed_orcids":["https://orcid.org/0009-0004-6181-9877"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jamshidian, Farid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082566756","display_name":"Diana B. Cherbavaz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cherbavaz, Diana","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052800490","display_name":"CARL N. YOSHIZAWA","orcid":"https://orcid.org/0000-0001-9202-8059","observed_orcids":["https://orcid.org/0000-0001-9202-8059"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshizawa, Carl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048859997","display_name":"Steven Shak","orcid":"https://orcid.org/0000-0002-0692-8227","observed_orcids":["https://orcid.org/0000-0002-0692-8227"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shak, Steven","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014192243","display_name":"Peter Andrew Kaufman","orcid":"https://orcid.org/0000-0003-3677-6807","observed_orcids":["https://orcid.org/0000-0003-3677-6807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kaufman, Peter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044143691","display_name":"Nancy E. Davidson","orcid":"https://orcid.org/0000-0003-1520-6442","observed_orcids":["https://orcid.org/0000-0003-1520-6442"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Davidson, Nancy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025364402","display_name":"Julie R. Gralow","orcid":"https://orcid.org/0000-0003-3837-9928","observed_orcids":["https://orcid.org/0000-0003-3837-9928"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gralow, Julie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022178171","display_name":"Yan W. Asmann","orcid":"https://orcid.org/0000-0002-8896-2647","observed_orcids":["https://orcid.org/0000-0002-8896-2647"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Asmann, Yan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5129597071","display_name":"Karla V. Ballman","orcid":"https://orcid.org/0000-0002-4492-0357","observed_orcids":["https://orcid.org/0000-0002-4492-0357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ballman, Karla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.5316345,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-expression","display_name":"HER2 expression","score":0.8740000128746033},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.949999988079071},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9679999947547913},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.7870000004768372},{"id":"https://openalex.org/keywords/n9831-trial","display_name":"N9831 trial","score":0.718999981880188},{"id":"https://openalex.org/keywords/hazard-ratio","display_name":"hazard ratio","score":0.800000011920929},{"id":"https://openalex.org/keywords/lymph-node-status","display_name":"lymph node status","score":0.5839999914169312},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.6460000276565552}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6606000065803528},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6370999813079834},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.5752999782562256},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5108000040054321},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.46889999508857727},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4268999993801117},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41780000925064087},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.4171000123023987},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4092999994754791},{"id":"https://openalex.org/C4692481","wikidata":"https://www.wikidata.org/wiki/Q169526","display_name":"Reverse transcription polymerase chain reaction","level":4,"score":0.39100000262260437},{"id":"https://openalex.org/C48023723","wikidata":"https://www.wikidata.org/wiki/Q856198","display_name":"Real-time polymerase chain reaction","level":3,"score":0.37929999828338623},{"id":"https://openalex.org/C2908728163","wikidata":"https://www.wikidata.org/wiki/Q415271","display_name":"Human Epidermal Growth Factor Receptor 2","level":4,"score":0.375},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3734999895095825},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.36320000886917114},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.3379000127315521},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.3303000032901764},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.3278999924659729},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.3230000138282776},{"id":"https://openalex.org/C10390562","wikidata":"https://www.wikidata.org/wiki/Q581809","display_name":"Spline (mechanical)","level":2,"score":0.321399986743927},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.30079999566078186},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.289900004863739},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2825999855995178},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2759000062942505},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.2621000111103058},{"id":"https://openalex.org/C90559484","wikidata":"https://www.wikidata.org/wiki/Q778379","display_name":"Expression (computer science)","level":2,"score":0.2614000141620636}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.4459904","doi":"https://doi.org/10.6084/m9.figshare.4459904","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.4459904","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.4459904.v1","doi":"https://doi.org/10.6084/m9.figshare.4459904.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.4459904.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.4459904","doi":"https://doi.org/10.6084/m9.figshare.4459904","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.4459904","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7136251502","https://openalex.org/W7137270162","https://openalex.org/W7136777740","https://openalex.org/W2161017965","https://openalex.org/W7137351562","https://openalex.org/W6939938733","https://openalex.org/W2602235125","https://openalex.org/W1992581630","https://openalex.org/W2056727404","https://openalex.org/W2021075165"],"abstract_inverted_index":{"Hazard":[0],"ratio":[1],"for":[2,32,38,48,60,76],"trastuzumab":[3],"benefit":[4],"as":[5],"a":[6,28,35,44,56],"continuous":[7],"function":[8],"of":[9,52,63,90],"HER2":[10,53,64],"expression":[11],"by":[12,14,17,54,65],"RT-PCR,":[13,55],"HR":[15],"status":[16,78],"local":[18],"IHC.":[19],"Estimate":[20],"and":[21,70,82,97],"95":[22,99],"%":[23,100],"confidence":[24,101],"limits":[25],"obtained":[26],"from":[27],"Cox":[29],"PH":[30],"model":[31],"DRFI":[33],"with":[34,67],"main":[36,50],"effect":[37,51],"treatment":[39,68],"arm":[40],"(C":[41],"versus":[42],"A),":[43],"natural":[45,57],"cubic":[46,58],"spline":[47,59],"the":[49,61],"interaction":[62],"RT-PCR":[66],"arm,":[69],"three":[71],"indicator":[72],"variables":[73],"to":[74],"adjust":[75],"nodal":[77],"(0,":[79],"1\u20133,":[80],"4\u20139":[81],"10+":[83],"positive":[84],"nodes).":[85],"Solid":[86],"line":[87],"=":[88,95],"estimate":[89],"hazard":[91],"ratio;":[92],"dashed":[93],"lines":[94],"lower":[96],"upper":[98],"limits.":[102],"(PDF":[103],"177":[104],"kb)":[105]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-03-17T00:00:00"}